-
平臺(tái)編號(hào)：bio-47792
-
國(guó)際編號(hào)：ATCC 50144
-
拉丁屬名： Trichomonas vaginalis
-
規(guī)格：frozen
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
Trichomonas vaginalis
ATCC? Number:50144?
Organism: Trichomonas vaginalis Donne
Designations: CDC 337
Isolation: human, Columbus, OH, 1983
Depositors: M Muller
History: ATCC<<--M Muller<<--J.G. Lossick
Biosafety Level:2
Shipped: frozen
Growth Conditions: ATCCmedium 2154: LYI Entamoeba mediumTemperature: 35.0°C Duration: axenic; anaerobic Protocol: at pH 6.0
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments: In vitro susceptibility of metronidazole [58183] Virus RNAs [24134]
References: 23976: Muller M. Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery 93: 165-171, 1983. PubMed: 6849201 24134: Tai JH, et al. The divergence of Trichomonas vaginalis virus RNAs among various isolates of Trichomonas vaginalis. Exp. Parasitol. 76: 278-286, 1993. PubMed: 8500587 58183: Muller M, et al. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex. Transm. Dis. 15: 17-24, 1988. PubMed: 3258675 70353: Bouma MJ, et al. Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus. J. Antimicrob. Chemother. 42: 817-820, 1998. PubMed: 10052908 70372: Adagu IS, et al. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J. Antimicrob. Chemother. 49: 103-111, 2002. PubMed: 11751773
ATCC50144
Organism: Trichomonas vaginalis Donne
Designations: CDC 337
Isolation: human, Columbus, OH, 1983
Depositors: M Muller
History: ATCC<<--M Muller<<--J.G. Lossick
Biosafety Level:2
Shipped: frozen
Growth Conditions: ATCCmedium 2154: LYI Entamoeba mediumTemperature: 35.0°C Duration: axenic; anaerobic Protocol: at pH 6.0
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments: In vitro susceptibility of metronidazole [58183] Virus RNAs [24134]
References: 23976: Muller M. Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery 93: 165-171, 1983. PubMed: 6849201 24134: Tai JH, et al. The divergence of Trichomonas vaginalis virus RNAs among various isolates of Trichomonas vaginalis. Exp. Parasitol. 76: 278-286, 1993. PubMed: 8500587 58183: Muller M, et al. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex. Transm. Dis. 15: 17-24, 1988. PubMed: 3258675 70353: Bouma MJ, et al. Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus. J. Antimicrob. Chemother. 42: 817-820, 1998. PubMed: 10052908 70372: Adagu IS, et al. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J. Antimicrob. Chemother. 49: 103-111, 2002. PubMed: 11751773
ATCC50144
